InsidersTradesSigma
Sunshine Biopharma, Inc Stock: price and management transactions · United States · SEC (Form 4)
Follow the Sunshine Biopharma, Inc stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, Sunshine Biopharma, Inc has recorded 5 insider filings. Market capitalisation: €4.4m. The latest transaction was filed on 5 March 2024 (Acquisition). Among the most active insiders: Slilaty Steve N.. All data is openly available.
5
Insider Decl.
0
Thresholds
€61,633
4 ops.
Buy Volume
€87,098
1 ops.
Sell Volume
45Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,436 of 26,211 companies
12.1
score / 100
Value1
Quality23
FCF yld-131%
Earn yld-127%
EV/EBITDA·
ROE-27%
Gross mgn34%
Net mgn-16%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 March 2024
Declarations5 total
100,000 shares@ US$0.109.4% of flowSeries B Preferred StockSEC:0001683168-24-001322:0
Ideal exit: 29 Nov 2024 (T+270)
20,000 shares@ US$0.101.9% of flowSeries B Preferred StockSEC:0001683168-24-000879:0
Ideal exit: 4 Nov 2024 (T+270)
30,000 shares@ US$0.763543.9% of flowCommon StockSEC:0001683168-22-008144:0
Ideal exit: 27 Aug 2023 (T+270)
25,000 shares@ US$1.220.65% mcap100.0% of flowCommon StockSEC:0001683168-22-004178:0
Ideal exit: 28 Feb 2023 (T+270)
990,000 shares@ US$0.102.00% mcap100.0% of flowSeries B Preferred StockSEC:0001683168-22-001185:0
5 of 5 declarations